Gestational Diabetes: Challenges and Cutting-Edge Research

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".

Deadline for manuscript submissions: 15 October 2025 | Viewed by 107

Special Issue Editors


E-Mail Website
Guest Editor
Department of Endocrinology Diabetes and Metabolism, Naval Hospital of Athens, Deinokratous 70, 11521 Athens, Greece
Interests: gestational diabetes; microbiota; neonatal morbidity; neonatal mortality; diabetes mellitus; bone metabolism

E-Mail Website
Guest Editor
Choremeio Research Laboratory, First Department of Pediatrics, National and Kapodistrian University of Athens, Thivon & Levadeias 8, Goudi, 11527 Athens, Greece
Interests: tumor biology; physical biology; bioinformatics; cell biology; genetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

Gestational Diabetes represents a serious health issue with a global prevalence of between 1% and 14%. Several factors play crucial role such as lactogenic hormone secreted from placenta, which desensitizes insulin and increases glucose levels during the final trimester; cortisone; estrogen and other hormones; maternal age; and genetic predisposition. When gestational diabetes is not recognized or not properly managed, it leads to an increased risk of certain conditions affecting both mother and newborn, such as pre-eclampsia, polyhydramnios, and fetal macrosomia.

Early detection and treatment results in a significant improvement in maternal and fetal health. Although the diagnosis causes fear in expectant mothers, when managed effectively, the condition may not cause health problems later. Furthermore, the majority of pregnant women have at least one risk factor and some of them are at higher risk. Testing is usually performed between 24 and 28 weeks of gestation with an oral glucose tolerance test, but in women with higher risk detection, it should be performed as early as possible 

This Special Issue will examine recent challenges in the diagnosis and management of gestational diabetes. In particular, we would appreciate original articles and literature reviews investigating novel potential pathophysiological mechanisms underlying gestational diabetes or advanced therapeutic approaches. Furthermore, studies exploring new molecular pathways with potential therapeutic applications or studies using AI for monitoring and treating pregnant women are welcome.

This Special Issue will be led by Dr. Athanasios N. Tsartsalis, with assistance from Dr. George I. Lambrou (National and Kapodistrian University of Athens, Greece).

Dr. Athanasios N. Tsartsalis
Dr. George I. Lambrou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gestational diabetes
  • continuous glucose monitor
  • fetal health
  • pregnancy
  • macrosomia
  • personalized management

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop